For one, rapid weight loss (whether from medication, diet, or other lifestyle habits) is known to temporarily disrupt hormonal levels
It signals your body to release more of its own naturally, which may reduce risks associated with direct hormone replacement
The result is a bioavailability profile sufficient to drive clinically meaningful weight loss, something the scientific community long considered impossible for peptide-based GLP-1s
They are well-liked since they are readily available and simple to use
Additionally, chronic pre-existing comorbidities are often associated with immune activation while the donor is still alive
The pharmacological effects won't be compromised by a single same-day administration, but tissue trauma risk is elevated